Liquid Diagnosis of Hepatic Encephalopathy: Are We There Already?

Overview

Journal GE Port J Gastroenterol

Specialty Gastroenterology

Date 2020 Nov 30

PMID 33251286

Authors

Mariana Verdelho Machado

Affiliations

Soon will be listed here.

References

Unden J, Ingebrigtsen T, Romner B . Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based update. BMC Med. 2013; 11:50. PMC: 3621842. DOI: 10.1186/1741-7015-11-50. View

Strebel H, Haller B, Sohn M, Schepp W, Gundling F . Role of Brain Biomarkers S-100-Beta and Neuron-Specific Enolase for Detection and Follow-Up of Hepatic Encephalopathy in Cirrhosis before, during and after Treatment with L-Ornithine-L-Aspartate. GE Port J Gastroenterol. 2020; 27(6):391-403. PMC: 7670347. DOI: 10.1159/000507225. View

Montoliu C, Cauli O, Urios A, ElMlili N, Serra M, Giner-Duran R . 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis. Am J Gastroenterol. 2011; 106(9):1629-37. DOI: 10.1038/ajg.2011.123. View

Karanfilian B, Park T, Senatore F, Rustgi V . Minimal Hepatic Encephalopathy. Clin Liver Dis. 2020; 24(2):209-218. DOI: 10.1016/j.cld.2020.01.012. View

Yao B, Zhang L, Ai Y, Liu Z, Huang L . Serum S100β is a better biomarker than neuron-specific enolase for sepsis-associated encephalopathy and determining its prognosis: a prospective and observational study. Neurochem Res. 2014; 39(7):1263-9. DOI: 10.1007/s11064-014-1308-0. View

Goh E, Stokes C, Sidhu S, Vilstrup H, Gluud L, Morgan M . L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database Syst Rev. 2018; 5:CD012410. PMC: 6494563. DOI: 10.1002/14651858.CD012410.pub2. View

Isobe-Harima Y, Terai S, Segawa M, Uchida K, Yamasaki T, Sakaida I . Serum S100b (astrocyte-specific protein) is a useful marker of hepatic encephalopathy in patients with fulminant hepatitis. Liver Int. 2008; 28(1):146-7. DOI: 10.1111/j.1478-3231.2007.01604.x. View

Kumral D, Qayyum R, Roseff S, Sterling R, Siddiqui M . Adherence to Recommended Inpatient Hepatic Encephalopathy Workup. J Hosp Med. 2019; 14(3):157-160. DOI: 10.12788/jhm.3152. View

Strauss G, Christiansen M, Moller K, Clemmesen J, Larsen F, Knudsen G . S-100b and neuron-specific enolase in patients with fulminant hepatic failure. Liver Transpl. 2001; 7(11):964-70. DOI: 10.1053/jlts.2001.28742. View

10.

Moore B . A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun. 1965; 19(6):739-44. DOI: 10.1016/0006-291x(65)90320-7. View

11.

Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen K . Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014; 60(2):715-35. DOI: 10.1002/hep.27210. View

12.

Otto M, Wiltfang J, Schutz E, Zerr I, Otto A, Pfahlberg A . Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study. BMJ. 1998; 316(7131):577-82. PMC: 28459. DOI: 10.1136/bmj.316.7131.577. View

13.

Qureshi M, Khokhar N, Shafqat F . Ammonia levels and the severity of hepatic encephalopathy. J Coll Physicians Surg Pak. 2014; 24(3):160-3. DOI: 03.2014/JCPSP.160163. View

14.

Foerch C, Singer O, Neumann-Haefelin T, du Mesnil de Rochemont R, Steinmetz H, Sitzer M . Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction. Arch Neurol. 2005; 62(7):1130-4. DOI: 10.1001/archneur.62.7.1130. View

15.

Ong J, Aggarwal A, Krieger D, Easley K, Karafa M, Van Lente F . Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med. 2003; 114(3):188-93. DOI: 10.1016/s0002-9343(02)01477-8. View

16.

Stammet P . Blood Biomarkers of Hypoxic-Ischemic Brain Injury after Cardiac Arrest. Semin Neurol. 2017; 37(1):75-80. DOI: 10.1055/s-0036-1593858. View

17.

Vaquero J, Jordano Q, Lee W, Blei A . Serum protein S-100b in acute liver failure: Results of the US Acute Liver Failure Study group. Liver Transpl. 2003; 9(8):887-8. DOI: 10.1053/jlts.2003.50172. View

18.

Cauli O, Rodrigo R, Llansola M, Montoliu C, Monfort P, Piedrafita B . Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy. Metab Brain Dis. 2008; 24(1):69-80. DOI: 10.1007/s11011-008-9115-4. View

19.

Sen J, Belli A . S100B in neuropathologic states: the CRP of the brain?. J Neurosci Res. 2007; 85(7):1373-80. DOI: 10.1002/jnr.21211. View

20.

Toney N, Bell M, Belle S, Hardison R, Rodriguez-Baez N, Loomes K . Hepatic Encephalopathy in Children With Acute Liver Failure: Utility of Serum Neuromarkers. J Pediatr Gastroenterol Nutr. 2019; 69(1):108-115. PMC: 6591057. DOI: 10.1097/MPG.0000000000002351. View